ML21019A159

Public Meeting Summary January 12 2021

ML21019A159
Person / Time
Site:	SHINE Medical Technologies
Issue date:	01/27/2021
From:	Jennifer Davis NRC/NMSS/DREFS/ENRB
To:	Robert Elliott NRC/NMSS/DREFS/ELRB
Davis J
References
EPID L-2019-NEW-0004
Download: ML21019A159 (5)

Text

UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 January 27, 2021 MEMORANDUM TO: Robert B. Elliott, Chief Environmental Review License Renewal Branch Division of Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards Signed by Davis, FROM: Jennifer A. Davis, Senior Project Manager on 01/27/21 Environmental Review New Reactor Branch Division of Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards

SUMMARY

OF PUBLIC MEETING CONDUCTED FOR THE SHINE MEDICAL TECHNOLOGIES, LLC OPERATING LICENSE APPLICATION ENVIRONMENTAL REVIEW (EPID NUMBER: L-2019-NEW-0004)

The U.S. Nuclear Regulatory Commission (NRC) staff conducted a public meeting (teleconference) related to the review of an operating license for the proposed SHINE Medical Technologies, LLC (SHINE) Medical Isotope Production Facility in Janesville, Wisconsin. The teleconference was conducted on January 12, 2021. The purpose of this meeting was to discuss NRC requests for additional information (RAI) dated December 18, 2020 (Agencywide Documents Access and Management System Accession Number ML20352A225). Specifically, the NRC staff requested information related to new or revised project plans occurring adjacent to the SHINE facility with respect to the production of lutetium-177, and the construction and operation of the proposed SHINE headquarters and therapeutics facility.

SHINE described its approach on how it will respond to the RAIs and asked clarifying questions.

NRC staff also asked clarifying questions related to the site layout, changes in staffing, transportation impacts, and characterization of waste streams. No sensitive or proprietary information was discussed during the teleconference.

CONTACT: Jennifer Davis, NMSS/REFS 301-415-3835

R. Elliott 2 Sixteen people participated in the public teleconference including representatives from the NRC and SHINE, and members of the public. A list of public meeting attendees is provided in . Enclosure 2 is a copy of the meeting agenda.

Action Items SHINE will submit responses to RAIs dated December 18, 2020 by February 1, 2021.

Docket Number: 50-608

Enclosures:

As stated

PUBLIC MEETING ATTENDEES January 12, 2021 PARTICIPANTS AFFILIATION Jennifer Davis U.S. Nuclear Regulatory Commission (NRC)

Nancy Martinez NRC Donald Palmrose NRC Steve Lynch NRC Phyllis Clark NRC William Rautzen NRC Robert Hoffman NRC Kevin Folk NRC Greg Casto NRC Mary Woods NRC Duane White NRC Jeff Bartelme SHINE Medical Technologies, LLC (SHINE)

Jim Costedio SHINE Eric Van Abel SHINE Robert S. No affiliation Jakub Simecek No affiliation

PUBLIC MEETING AGENDA

SHINE Medical Technologies, LLC Operating License Application Environmental Technical Discussion January 12, 2021, 09:00 AM to 10:00 AM Teleconference Time Topic Speaker 9:00 am Welcome and Purpose of Meeting NRC 9:05 am Technical Discussion NRC/SHINE 9:45 am Public Questions/Comments Public/NRC 9:55 am Closing NRC ENCLOSURE 1

Memo ML21019A159 NMSS/REFS NMSS/REFS NMSS/REFS OFFICE NMSS/REFS/ERLRB

/ERNRB /ERLRB /ERNRB NAME JDavis JD NMartinez NM RElliott RE JDavis JD DATE Jan 22, 2021 Jan 25, 2021 Jan 26, 2021 Jan 27, 2021